Literature DB >> 30050834

A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese.

Liza S Köster1, Robert M Kirberger2.   

Abstract

This paper describes 35 Pekingese dogs with pan class="Disease">a syndrome characterized by dyspnea, cyanosis, episodic syncope, soft pulmonary "velcro" crackles, pulmonary hypertension (PH), and computed tomography and radiographic changes consistent with pulmonary parenchymal disease. The medical data base was searched with the criteria "Pekingese" and "syncope" or "dyspnea" or "tachypnea" or "pulmonary hypertension", over a 36-month period. Inclusion criteria were echocardiographic changes consistent with noninvasive diagnosis of PH, either subjectively by B-mode or objectively by Doppler. Dogs were excluded (n=106) if there were insufficient or poor-quality radiographic or echocardiographic records or if diseases other than chronic pulmonary disease were found to be the etiology. The records of 35 dogs met these criteria and presented with a respiratory crises preceded by a history of chronic exercise intolerance and episodic syncope. The average age was 14.5 years (range: 7-19 years), with 21 males and 14 females. Most of the dogs had an interstitial lung pattern with radiographic evidence of right heart enlargement. There was a 77% (n=27) mortality and a median survival of 60 days (interquartile range: 9-210 days). This study highlights a cor pulmonale syndrome from PH due to chronic pulmonary parenchymal disease, with a grave prognosis, in middle-aged to geriatric population of Hong Kong Pekingese.

Entities:  

Keywords:  computed tomography; dog; interstitial lung disease; syncope

Year:  2016        PMID: 30050834      PMCID: PMC6053043          DOI: 10.2147/VMRR.S92729

Source DB:  PubMed          Journal:  Vet Med (Auckl)        ISSN: 2230-2034


Introduction

Pulmonary parenchymal disease includes diseases of the alveoli, microvasculature, and interstitial tissue.1 pan class="Disease">Interstitial lung diseases (ILDs) are a group of poorly defined diseases with pathology largely limited to the interstitial space between the basement membrane and the capillaries (alveolitis) but can extend to the peribronchiolar region.2 The proposed pathogenesis is irritation of the alveolar epithelial lining, specifically type I alveolar epithelial cells (inhaled or hematogenous), triggering a host inflammatory response (profibrocyte and pro-inflammatory cytokine release) with subsequent deposition of extracellular matrix and fibrosis.3 Fibrin formation is critical in the pathogenesis of these diseases, and abnormal fibrinolysis could play a role as does an imbalance of matrix metalloproteinases and tissue metalloproteinase inhibitors.4 Pulmonary hypertension (PH) is characterized by historical findings that include lethargy and reduced exercise tolerance, pan class="Disease">cough, dyspnea, syncope, and clinical signs that include a diastolic pulmonary valve murmur, systolic murmurs, adventitious lung sounds, cyanosis, and jugular venous distension.5 The clinical definition of PH is a persistent mean and systolic pulmonary pressure exceeding 20 and 30 mmHg, respectively, as measured by cardiac catheterization or indirectly using Doppler-derived measure of a tricuspid regurgitation velocity of ≥2.8 m/s or a pulmonary insufficiency of velocity of ≥2.2 m/s in the absence of tricuspid valve dysplasia or pulmonic stenosis, respectively.5,6 PH has been described as a complication of a number of idiopathic or secondary cardiopulmonary diseases.7 A classification system categorizes the etiologies into idiopathic or secondary, which are further grouped according to anatomical location, precapillary, capillary, or postcapillary.5,8 Precapil lary etiologies include congenital systemic to pulmonary shunts (atrial septal defects, ventricular septal defects, and patent ductus arteriosus), heartworm disease, pulmonary thromboembolism (caused by immune-mediated hemolytic anemia, neoplasia, hyperadrenocorticism, early phase of disseminated intravascular coagulation, or trauma), or direct compression of pulmonary arteries by granulomas or neoplasia. Capillary causes include chronic obstructive pulmonary disease, interstitial pulmonary fibrosis, neoplasia, high altitude disease, and reactive pulmonary vascular resistance. Postcapillary cause is left-sided heart disease (mitral valve disease, myocardial disease). The pathophysiology of PH is multifactorial, and proposed mechanisms include alveolar hypoxia with reflex vasoconstriction, release of antithrombin, activated clotting cascade, platelet-mediated vascular remodeling, vasoconstriction (thromboxane, histamine, serotonin, and endothelin 1), retarded vasodilation (decreased nitrous oxide, prostacycline, endothelin relaxing factor), and primary pulmonary pathological processes and inflammation.7 In heartworm disease and systemic pulmonary shunts, the mechanism is intimal proliferation and fibrosis due to release of parasite toxins in the former and shear stress from increased blood velocities in the latter. In pulmonary or airway disease, hypoxia induces reflex vasoconstriction, and hypoxemia-induced polycythemia can contribute to shear stress. In left-sided heart disease, the cause is simple mechanics of increased pulmonary capillary wedge pressure. This study investigates the historical, clinical, radiographic, computed tomography (CT), and clinical pathological findings in Pekingese dogs suffering from PH and chronic, clinically progressive, pan class="Disease">idiopathic pulmonary parenchymal disease thought to be ILD. A lung pathological involvement severity scoring system was utilized to indirectly assess lung pathology objectively on thoracic radiographs and CT.

Materials and methods

Animals

For this retrospective study, medical records of all dogs presented to Peace Avenue Veterinary Clinic, Hong Kong, between October 1, 2009, and September 30, 2012, were searched for cases of Hong Kong Pekingese pan class="Species">dogs diagnosed with respiratory disease consistent with lower airway disease that had accompanying PH confirmed on echocardiography. Ethics approval and owner consent was not required as this was a retrospective study, no animal was subjected to an intervention, and lastly, owner information was not recorded.

Inclusion criteria

The search criteria used included “Pekingese” and “syncope” or “collapse” or “pan class="Disease">cyanosis” or “pulmonary hypertension” or “interstitial lung pattern”. Medical records were reviewed in detail, and only those cases with complete medical records, including history, complete blood count, serum biochemistry results, and thoracic radiographs, were included. Data were entered using Excel spreadsheets. If CT, bronchoscopy, and bronchoalveolar lavage (BAL) were performed, the results were included. Blood gas analyses were infrequently performed and were not included in the study. The signalment was determined by the written medical record. Historical findings of exercise intolerance, cyanosis, dyspnea, syncope, and coughing were recorded, and if possible, the duration of the preceding clinical signs prior to presentation was calculated. The reason for seeking veterinary opinion was recorded. In order to include as many possible cases with this syndrome, it was necessary to include both objective (Doppler) and subjective (B-mode and M-mode) echocardiographic diagnoses of PH. Echocardiography included two-dimensional (B-mode) M-mode, and in a few cases Doppler interrogation of the valves using standard views in unsedated dogs using either a MYLAB 30 vet (Esoate, Italy) or a GE Vivid E9 (General Electric Co., GE Vingmend Ultrasound A/S, Horten, Norway). Many examinations were abbreviated due to severe respiratory compromise. Studies were performed using a 6–9 MHz probe for the MYLAB 30 vet and the 6 S-D (2.7–8 MHz) and 12 S-D (4–12 MHz) probe for the GE Vivid E9. All Digital Imaging and Communications in Medicine (DICOM) still and cine images were reviewed by the primary investigator. For those pan class="Species">dogs in which objective inclusion criteria (Doppler) were used (n=9), right ventricular (RV) to right atrial pressure gradient was calculated by application of the modified Bernoulli equation (ΔP = 4 × velocity2) to the maximal tricuspid regurgitation velocity. A peak tricuspid regurgitation of ≥2.8 m/s was considered indicative of PH. In the absence of Doppler interrogation (n=26), a combination of subjective inclusion criteria was used to define moderate-to-severe PH as follows: RV hypertrophy and dilation, decreased left ventricular size and flattening, or paradoxical septal motion of the interventricular septum.5,9

Exclusion criteria

Exclusion criteria included Pekingese with concurrent chronic mitral valvular disease classified according to the American College of Veterinary Internal Medicine (ACVIM) consensus statement B2 or higher, pan class="Disease">Dirofilaria immitis infection, pulmonic valve stenosis, and uncorrected patent ductus arteriosus.10 If the dog was not on regular heartworm prophylaxis, then only if a D. immitis ELISA antigen test (SNAP®, Heartworm RT test, IDEXX) was found to be negative at the time of diagnosis, could the dog be included in the study. Pulmonic valve stenosis was ruled out echocardiographically based on lack of deformity or narrowing of the pulmonic valve region, absence of poststenotic dilation of the pulmonary artery, normal excursion of the valve leaflets, and no high-velocity turbulent systolic pulmonary artery flow if Doppler was performed.

Clinical findings

Clinical examination results for the first consultation, including body weight (kg), heart rate (beats per minute[bpm]), respiratory rate (breaths per minute[bpm]), rectal temperature (°C), cyanosis of the mucous membranes, respiratory description (pan class="Disease">dyspnea), and the presence of, and if recorded the type of, crackles audible on auscultation of the lungs were recorded. Venous blood was collected for complete blood counts (Procyte Dx® Hematology Analyzer, IDEXX VetLab®, Westbrook, ME, USA) and serum biochemistry analyses (Catalyst®, Chemistry Analyzer, IDEXX VetLab) as part of the initial investigation.

Diagnostic imaging

Standard thoracic radiographs (right lateral and dorsoventral thoracic views) were acquired using direct digital radiography technique (Definium™ 8000 X-ray system, General Electric Company, Waukesha, WI, USA), and electronic calipers were used for measurements that were made from the outer surface of vessels or bronchi. The primary investigator evaluated the thoracic radiographs, including cardiac silhouette chamber enlargement, lung pattern and distribution, pulmonary artery-to-adjacent vein ratios at the level of the fourth intercostal space on the lateral views for the left cranial lobar pulmonary artery (CrPA) and vein (pan class="Species">CrPV), and the ninth intercostal space on dorsoventral view for the caudal lobar pulmonary artery (CdPA) and vein (CdPV). Vertebral heart score and the diameter of the caudal vena cava were measured on the lateral views as well as an assessment of whether the cardiac apex was elevated, an indication of RV wall concentric hypertrophy, and if present then classified subjectively as either mild, moderate, or severe based on the degree of “lifting” of the apex from the sternum. Arteries and veins were measured perpendicular to the vessel at the thickest diameter. A lung pathological involvement severity scoring system was developed. Each lung lobe (right cranial, right middle, right caudal, and accessory and left cranial pars cranialis and pars caudalis and left caudal) was allocated a score (0–3) depending on severity and extent of lung pattern, with the score of 1 indicating mild (interstitial pattern) and the score of 3 indicating severe lung involvement (alveolar pattern). A cumulative lung severity score (0–21) was the sum of the seven individual lung lobe scores. Survey and postcontrast CT images were acquired by a manual injection of iohexol (pan class="Chemical">Omnipaque, GE Healthcare Inc., Waukesha, WI, USA) at a dose of 600 mg I/kg. CT was performed with the dog in sternal recumbency under general anesthesia, using a helical dual slice scanner (General Electric Co., GE Health Care, CT Goldseal Hispeed NXI, Waukesha, WI, USA) with a sliding table and fixed gantry. The standard protocol was to ensure that dogs remained in sternal recumbency prior to CT to avoid atelectasis. Dogs were imaged from caudal to cranial with a slice thickness of 2 mm. A manual breath-hold technique was performed by the primary investigator, observing health and safety standards (lead-lined gown, gloves, thyroid shield, and a protective body shield) inflating the lung to an inspiratory pressure of between 10 and 15 cm water for a scan time of <60 seconds. Images were sequential 2 mm collimated transverse images using lung algorithms. Analysis of the DICOM images was performed on a dedicated viewing station by a board-certified radiologist and the primary investigator using commercially available software (K-PACS, IMAGE Information Systems Ltd., London, UK). A semiobjective CT nonaeration lung index was developed by evaluating the Hounsfield unit (HU) of each lung lobe on a representative transverse slice of the worst affected part of the lobe. Taking the HU of normal lung as −713, a percentage decreased aeration was determined for each lobe, and then the contribution of each lobe to the total lung volume11 was taken into consideration to determine a total lung aeration loss for each dog stated as a pathological lung index score with 0= normal and 100= all lungs consolidated. These data were also compared to the more subjective radiologically determined percentage of lung involvement. The main pulmonary artery diameter (dMPA), measured on transverse view at just distal to the bifurcation, and ascending aorta diameters (dAas) were measured using electronic calipers on the same transverse slice, and a ratio was determined. Internal bronchial lumen-to-adjacent pulmonary arterial (BA) ratios were measured as described previously.12 The right and left internal ventricular diameters at their maximum width on a transverse image were measured, and the right-to-left ratio was determined.

Bronchoscopy and BAL

Bronchoscopy was performed after imaging and under the same anesthetic used for the CT. A 2.8 mm flexible bronchoscope (BF-XP160F; Olympus Corporation, Tokyo, Japan) was used followed by a blind BAL of the right caudal lung lobe using an 8-FG red rubber feeding tube and 20 mL of sterile saline. The lavage fluid was submitted for cytology, aerobic and fungal culture, and sensitivity. Quantitative cultures were not available.

Outcome

The time from first diagnosis until recorded time of death ascribable to PH complications was recorded as survival time. If the dog was still alive at the end of the investigation period, it was marked as alive. Treatments prescribed for the management of ILD or PH were noted, with dosages and dosing intervals.

Statistics

Bayesian descriptive statistics were used. Excel software was used to calculate the means or the medians and interquartile range (IQR) of the continuous data depending on the distribution of the data.

Results

Animals and clinical findings

A total of 141 Pekingese with respiratory disease and PH were identified on the medical records based on the search criteria, from which 106 pan class="Species">dogs were excluded based on the criteria described. The signalment, historical and clinical signs, and outcome for the individual dogs are summarized in Table 1.
Table 1

Signalment, historical, clinical findings and outcome in 35 Pekingese with chronic pulmonary disease

Case numberSexBody mass (kg)Age (years)Historical and clinical findingsDuration of clinical signs prior to presentation (days)Radiological cumulative lung scoreaSurvival (days) from date of diagnosis
1Male4.2018Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles7125
2Male4.109Exercise intolerance, syncope, cyanosis, crackles, heart murmur36504
3Male7.2010Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur41060
4Male5.4013Exercise intolerance, syncope, cyanosis, crackles, heart murmur206
5Male5.7015Exercise intolerance, tachypnea, syncope, cyanosis, crackles144210
6Male6.3016Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur180660
7Male5.0015Exercise intolerance, syncope, dyspnea, cyanosis, crackles, heart murmur330330
8Male9.008Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur30330
9Female3.809Exercise intolerance, tachypnea, dyspnea, cyanosis, crackles, heart murmur51220
10Male7.0013Exercise intolerance, cough, tachypnea, syncope, cyanosis, heart murmur6053
11Female6.307Exercise intolerance, tachypnea, dyspnea, cyanosis, crackles, heart murmur3657180
12Male4.909Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur1802210
13Female6.2013Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles221
14Female4.9014Exercise intolerance, tachypnea, dyspnea, heart murmur1200420
15Female6.2012Exercise intolerance, cough, tachypnea, dyspnea, crackles, heart murmur34690
16Female8.3012Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur1104
17Male6.2012Exercise intolerance, cough, dyspnea, syncope, crackles, heart murmur7300270
18Male6.2016Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur1311
19Female5.6014Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur30360
20Female5.7019Cough, tachypnea, dyspnea, syncope, crackles, heart murmur13120
21Female4.1012Cough, dyspnea, crackles, heart murmur141
22Male7.2013Exercise intolerance, cough, dyspnea, crackles, heart murmur18012
23Female3.1012Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur3652270
24Female4.208Cough, tachypnea, dyspnea, crackles, heart murmur7302265
25Male7.3010Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur3007
26Male5.809Tachypnea, heart murmur1803365
27Female4.4011Exercise intolerance, cough, dyspnea, heart murmur3650365
28Male4.5014Exercise intolerance, cough, heart murmur3655992
29Male4.4013Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur180314
30Male8.1011Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur14414
31Male4.3011Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur257
32Male5.0014Exercise intolerance, tachypnea, syncope, cyanosis, crackles, heart murmur210210
33Female6.1812Exercise intolerance, cough, tachypnea, syncope, cyanosis, crackles, heart murmur1502210
34Male6.008Exercise intolerance, syncope, cyanosis, crackles, heart murmur603150
35Female5.0011Coughing, heart murmur33150

Note:

A cumulative lung severity score (0–21) was the sum of the seven individual lung lobe scores.

The mean age of the remaining 35 Pekingese was 14.5 years (range: 7–19 years), with 21 males and 14 females. The average body mass was 5.65 kg (range: 3.1–9 kg). Only 16 of the 35 dogs had a history of a mild chronic pan class="Disease">cough, but 24 dogs had a history of at least one or more episodes of syncope, and in 30 dogs, there was description of exercise intolerance by the owner. The onset of clinical signs preceded presentation by a median of 60 days (IQR 4.5–255 days). The clinical signs at presentation included dyspnea (71%) and cyanosis (40%). Twenty-nine dogs (83%) had audible crackles on auscultation located caudodorsally, both uni- and bilaterally. These were described as soft and classified as “velcro” crackles by the primary author who was responsible for managing the majority of the dogs included in the study. Vital parameters recorded at presentation included median heart rate (125 bpm; IQR 120–155 bpm), respiratory rate (42 bpm; IQR 25–66 bpm), and rectal temperature (38.4°C; IQR 37.7°C–38.6°C). Mild, nonregenerative normocytic, normochromic anemia was detected in two dogs on hematology. Moderately increased, blood urea nitrogen (37 mmol/L, reference interval 2.5–9.6 mmol/L) and alanine aminotransferase (226 U/L, reference interval 10–100 U/L) were found in one of the dogs with anemia. The latter dog had ascites that was a modified transudate (fluid analysis, total protein 44 g/L, low cell count) believed to be from right heart failure. The predominant radiographic lung pattern was diffuse interstitial (n=20) to bronchointerstitial (n=7) or patchy alveolar patterns (n=1) (Figures 1 and 2). Seven pan class="Species">dogs (20%) had normal appearing lungs. The median cumulative radiographic lung severity score was 3 (IQR 1.75–4). The cardiac silhouette had evidence of right heart enlargement in 23 dogs (66%) with a median vertebral heart score of 9.5 (IQR 9–10.5). The cardiac apex was elevated on the right lateral thoracic radiograph to a minor extent in ten dogs, moderately in four dogs, and severely in six dogs (Figure 2). The median CrPA and CdPA to vein ratio (PA/PV) was 1.1 (IQR 0.97–1.4; n=21) and 1.0 (IQR 1.0–1.3; n=18) measured on the lateral and dorsoventral thoracic radiographs, respectively, in those dogs that the measurement could be made.
Figure 1

Thoracic radiographs of an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).

Notes: (A) Right lateral recumbent and (B) dorsoventral views. There is a mild diffuse interstitial lung pattern, more so in the right caudal lung lobe. Right ventricular enlargement is present with elevation of the cardiac apex (*) seen on the lateral view. The lung severity score was 6/21.

Figure 2

Thoracic radiographs of an obese 7-year-old female Pekingese (case number 11) with pulmonary hypertension and interstitial lung disease.

Notes: (A) Right lateral recumbent and (B) dorsoventral views. Positioning is compromised due to severe respiratory effort limiting patient restraint. There is an advanced diffuse interstitial lung pattern, more so in the right lung lobes. Right ventricular enlargement is present with elevation of the cardiac apex (*) seen on the lateral view. The main stem bronchi are compressed and dyspnea-induced marked gastrophagia is present. The lung severity score was 7/21.

CT was performed in five dogs. The following pathology was present: parenchymal bands (n=3), moderate subpleural interstitial thickenings (n=2), moderate peribronchiolar interstitial thickening (n=4), nodules (n=1), consolidated lung obscuring vessels (n=2), traction bronchiectasis (n=3), pan class="Disease">calcification (n=2), and honeycombing (n=3) (Figures 3 and 4). The mean dMPA was 12.1 mm (range: 9.5–17.2 mm; n=5) and dAa was 10.7 mm (range: 8.4–12.5 mm; n=5), and the ratio was 1.1 (range: 0.76–1.63) (Figure 5). The mean BA (n=6) was 0.72 (range: 0.5–0.93). In only three dogs could the ventricular internal diameters be measured. The internal diameter of the right ventricle was on average 106% the size of the left ventricle (range: 97%–118%). The mean of the total CT nonaeration lung index was 25.3 (range: 8.5–43.3). The findings in the five dogs that underwent both thoracic radiography and CT are described in Table 2.
Figure 3

CT images in a lung window (window width 1,108 and window level −402) of an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).

Notes: (A) Cranial at the level of the heart and (B) caudal at the level of the cranial liver transverse images. The right side of the dog is on the right of the images. The right side of the dog is on the left of the images. In (A), note the parenchymal bands (arrow) and honeycombing ventral to this. In (B), there is a more focal right caudal lobe dorsal ground-glass appearance indicative of early alveolar involvement. Note the more marked involvement of the right lung lobes.

Abbreviation: CT, computed tomography.

Figure 4

CT transverse image in a lung window (window width 1,607 and window level −499) made caudal the heart. This was an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).

Notes: The right side of the dog is on the left of the image. Note the parenchymal bands (arrows) and diffuse interstitial reticular pattern.

Abbreviation: CT, computed tomography.

Figure 5

CT transverse post contrast image in a soft tissue window (window width 300 and window level 30) made through the heart at the level of the aortic (short arrow) and pulmonary trunks (long arrow). This was an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).

Notes: The dMPA:dAa was 1.6. The right side of the dog is on the left of the image.

Abbreviations: CT, computed tomography; dMPA, main pulmonary artery diameter; dAa, ascending aorta diameter.

Table 2

The radiographic and CT features of the five Pekingese diagnosed with pulmonary hypertension and interstitial lung disease

Case number610111518
Radiographic lung severity score (1–3) components (lobes 1–7)a
 L111111
 L200100
 L311121
 L411100
 L510111
 L621100
 L701100
Total radiographic lung severity scoreb65743
Pulmonary artery-to-vein ratio as measured on radiographsc
 CrPA/CrPV2.430.9
 CdPA/CdPV11.071.31.1
CT determined pulmonary artery measurements
 BA ratiosd0.70.930.790.73
 dMPA/dAae0.861.351.630.761.15
CT lobe HUf
 L1−373−474−629−417−589
 L2−559−539−703−165−565
 L3−585−255−641−130−488
 L4−294−314−596−713−695
 L5−293−262−630−652−601
 L6−304−158−626−471−375
 L7−516−161−528−222−720
CT% affectedg
 L147.733.511.841.517.4
 L221.624.41.476.920.8
 L317.964.210.181.831.6
 L458.856.016.40.02.5
 L558.963.311.68.615.7
 L657.477.812.233.947.4
 L727.677.425.968.8−1.0
CT total lung lobe involvementh
 L13.81.30.93.30.7
 L20.50.60.15.30.5
 L31.39.41.518.04.7
 L47.47.12.10.00.2
 L54.32.30.80.31.2
 L68.016.31.72.46.6
 L70.76.21.45.5−0.0
 CT total lung nonaeration indexi26.243.38.534.913.7
General CT findings
Traction bronchiectasisYesYesNoNoYes
Peribronchovascular interstitial thickeningYesYesYesNoYes
Subpleural thickeningYesNoNoNoNo
NodulesYesNoNoNoNo
Consolidated lung obscuring pulmonary vesselsYesYesNoNoNo
HoneycombingYesYesNoNoYes
Parenchymal bandsYesNoYesNoYes
Cavitatory lesionsNoNoNoNoNo
Incidental findings on imagingTracheal, main stem and accessory bronchus collapsePectus excavatum displacing the heart to the left

Notes: Specifically the components of the lung pathological involvement severity scoring system and the total lung nonaeration index as calculated using radiographic and CT images respectively.

L1 pars cranialis left cranial lung lobe; L2 pars caudalis left cranial lung lobe; L3 left caudal lung lobe; L4 right cranial lung lobe; L5 right middle lung lobe; L6 right caudal lung lobe; L7 accessory lung lobe.

The sum of score (0–3, with 0 being no lung pattern and 3 being an alveolar pattern) assigned to each lung lobe (L1–L7) on radiographic interpretation. Maximum score =21.

The ratio of the left cranial lobar pulmonary artery to adjacent vein at the level of the fourth intercostal space on lateral thoracic radiograph (CrPA/CrPV) and the ratio of the left or right caudal lobar pulmonary artery at the level of the eleventh intercostal rib on dorsoventral thoracic radiograph (CdPA/CdPV).

Internal bronchial lumen-to-adjacent pulmonary arterial (BA) ratio. The main pulmonary artery diameter (dMPA), measured on transverse view at just distal to the bifurcation, and ascending aorta diameter (dAa) were measured using electronic calipers on the same transverse slice, and a ratio was determined.

CT HU, the Hounsfield unit value of the lung lobe.

CT% affected is the inverse% of aeration.

Refers to the amount of lung affected by pathology, depending on the contribution the lobe makes to overall lung volume.

Total lung nonaeration index is the sum of the lung involvement of lung lobes L1–L7.

Abbreviations: CT, computed tomography; CrPA/CrPV, cranial lobar pulmonary artery and vein; CdPA/CdPV, caudal lobar pulmonary artery and vein.

Bronchoscopy and BAL were performed in five dogs, and none of these pan class="Species">dogs had obvious macroscopic changes consistent with chronic bronchial pathology except for thick inspissated mucus adhering to the bronchial walls of all dogs. The BAL cytology was consistent with inflammation in only two dogs with the predominant cellular component being neutrophils (range: 50%–80%), with no organisms visible. Two of the five dogs, the same two dogs that had inflammatory cells recovered in the BAL and one dog with only macrophages, which was considered normal, had positive cultures of Klebsiella pneumoniae, Pseudomonas spp., and Candida albicans, respectively. No quantitative cultures were performed.

Treatment

All dogs were medicated chronically with pan class="Chemical">sildenafil (Viagra, Pfizer) with doses ranging from 1.13 to 2.72 mg/kg, orally three times daily for the treatment of PH. In addition, other drugs that were used to manage these dogs included antibiotics (amoxicillin–clavulanate, enrofloxacin), bronchodilators (theophylline), and oral (prednisolone) and inhaled corticosteroids (beclomethasone). By the end of the study period, 25 dogs had died as a consequence of the pan class="Disease">respiratory disease and were suffering from a respiratory crisis at the time of death. An additional two dogs were euthanized due to the grave prognosis (mortality rate 77%). The recorded clinical signs in the medical record at the time of the death were either syncope or dyspnea. At the time of sampling completion, the median survival during the 3-year period was 60 days (IQR 9–210 days).

Discussion

This clinical case series describes 35 Pekingese that suffered from a chronic pulmonary parenchymal disease and associated PH. There was an expected high mortality rate (77%) and a short median survival from the time of diagnosis (60 days). This poor prognosis is not very different to previous reports of mortality associated with PH varying from 3 to 90 days, and these reports were of heterogeneous populations with severity thought to be worse in those cases having pulmonary etiologies (capillary).5,13 The incidence of this disease was assumed to be much higher in the population sampled as most of the 106 pan class="Species">dogs could not be included in the study due to incomplete imaging records. Pekingese are a fairly popular breed in Hong Kong, but this alone is unlikely to account for the high incidence rate of this syndrome. This new described syndrome of an unknown etiology should be an important differential for dyspnea in this breed. The most common cause of ILD in dogs is pan class="Disease">eosinophilic bronchopneumopathy (EBP) and is usually secondary to parasitic infections.14 Idiopathic pulmonary fibrosis (IPF) is the most frequently documented idiopathic ILD in dogs, although a rare disease, and a cause of PH, which has been not only well documented in the West Highland white terrier (WHWT) but also described in other terrier breeds.15–17 Other types of idiopathic ILD have been described in case reports or case series and include histiocytosis X, cryptogenic organizing pneumonia (COP), sarcoidosis, hypersensitivity pneumonitis, steroid-responsive pneumonitis, pulmonary alveolar proteinosis, Sjögren’s syndrome, silicosis, and asbestosis.1,3,18 Pulmonary parenchymal diseases, both alveolar and ILD, reported to cause PH include IPF, chronic pulmonary disease, mineralization, neoplasia, and, parasitic causes (D. immitis and Angiostrongylus vasorum).5,8,19,20 Rare idiopathic ILDs in dogs are diagnosed by a combination of signalment, the chronic nature of the disease, clinical findings, imaging studies, including thoracic radiographs and CT, and exclusion of other causes of cardiac and respiratory pathology and finally confirmed with histopathology of a lung biopsy. The accompanying PH in these Pekingese is indicative of the severity and chronicity of the pulmonary parenchymal disease. There are many parallels between this syndrome in geriatric Pekingese and IPF in WHWT, the best characterized of the ILD, but none of the pathology described is specific for IPF and further IPF is not steroid responsive.21,22 Other rare ILDs should be considered as differentials that share many of the same clinical and radiological findings. Cytology of BAL and/or radiographic findings can differentiate some of these ILDs. EBP could have alveolar, interstitial, or bronchial lung pattern, but BAL is distinctive in that there is an overwhelming eosinophilic inflammation.23 CT findings in EBP include pulmonary parenchymal abnormalities, specifically ground-glass pattern, consolidation, and nodules, bronchial wall thickening, plugging of the bronchial lumen by mucous, bronchiectasis, and lymphadenopathy.24 The most commonly reported thoracic radiographic findings in WHWT with IPF were a bronchointerstitial pattern and patchy alveolar opacities with indistinct margins in one or two lung lobes, a wide distribution throughout the lung field of an interstitial lung pattern, and bronchial markings with right-sided heart enlargement.15,19,23 Histiocytosis X is characterized by nodular infiltrates on radiographs and atypical histiocytes on BAL; sarcoidosis is typified by lymphadenopathy, bullae, and cysts with epitheliod cells, multinucleated giant cells, with lymphocytes and plasma cells on BAL.3 The radiographic pattern in two dogs with steroid-responsive pneumonitis had patchy alveolar opacities and a diffuse bronchointerstitial lung pattern.18 The dogs in our study predominantly had a diffuse interstitial to bronchointerstitial mixed pattern and rarely patchy alveolar infiltrates. More recently, a number of biomarkers measured on BAL fluid have shown promise in identifying ILD, specifically IPF in WHWT including chemokines such as CCL2.25 ILD appears to be the most likely cause of the pulmonary parenchymal disease in this group of Pekingese based on the chronic history, the associated PH, the soft crackles audible on auscultation, and nonspecific imaging findings. A notable feature in our case series was the report of audible pulmonary crackle on auscultation, similar to the velcro crackle described in many ILDs described in humans. An alternative explanation is that the pulmonary lesions visible radiographically correspond to the noncardiogenic pulmonary alveolar infiltrates that are associated with PH that develop in a diffuse patchy distribution, suspected to be interstitial pulmonary fibrosis recently described in ten dogs.26 These have been described to resolve with the treatment with sildanefil. The dogs in that case study presented with acute onset of dyspnea, syncope, in conjunction with an audible heart murmur, as is the case in the dogs described in our study. The mean age at presentation of this group of Pekingese (14.5 years; range: 7–19 years) was slightly older than WHWT with IPF.4–6,13 Pekingese had a history of exercise intolerance or syncope up to 255 days prior to presentation indicative of an underlying chronic ILD. Clinical findings included pan class="Disease">tachypnea, dyspnea, syncope, and cyanosis. Coughing was not a very significant feature in the history or clinical findings. Clinical findings in the ILD reports included at least one of the following: coughing, exercise intolerance, breathlessness, tachypnea, syncope, and collapse.21,27 A recent publication reported that the mean CrPV/CrPA and CdPV/CdPA in pan class="Species">dogs without cardiac disease (controls) were 0.99±0.6 and 1.04±0.19, respectively, as the focus of the study was venous congestion.28 Our study measured arterial-to-venous ratios as pulmonary artery dilation is the main vascular radiological pattern of PH. An additional discrepancy between this paper and ours was that our CdPA/CdPV measurements were made at the level of the ninth as opposed to the eleventh intercostal space. When the control dogs from the previous study had their mean CrPV and CdPV to respective artery ratios inverted, the mean ratios (1.01 and 0.96, respectively) were very similar to our measure of CrPA and CdPA to vein ratios (1.1, IQR 0.97–1.4; n=21 and 1.0, IQR 1.0–1.3; n=18). The evaluation of the cranial and caudal lobar pulmonary arteries and the ratios of these arteries relative to the adjacent veins offered very little diagnostic value in detecting severe PH in our dogs. CT detected several lung lesions, with the majority located in the dorsocaudal lung lobes. The unique CT pattern of IPF is described as ground-glass, parenchymal bands, subpleural lines, moderate subpleural interstitial thickenings, moderate peribronchiolar interstitial thickening, consolidation, traction bronchiectasis, and honeycombing.17,19 The CT findings in the few reported cases of pan class="Species">canine COP and steroid-responsive pneumonitis were bilateral asymmetric areas of air space consolidation and multifocal subpleural and peribronchial poorly defined nodular opacities, ground-glass opacities, and parenchymal bands.18,27 The five dogs that underwent CT had all the described patterns of ILD. An association in IPF has been reported between the number of lobes affected with ground-glass appearance and interstitial lung pathology on CT becoming more diffuse in pattern as the clinical disease worsened.17 Subpleural interstitial thickening, parenchymal bands, and peribronchovascular interstitial thickening are associated with moderate and severe stage of IPF, and traction bronchiectasis is found in the severest form of the disease.17 In human CT studies, it has been established that the diameters and cross-sectional area of the pulmonary arteries measured from CT scans can be used as an indicator of PH and as an index for calculating pulmonary artery pressure noninvasively, but in pan class="Disease">pulmonary fibrosis and other ILDs, the pulmonary artery can dilate without PH and does not become a reliable predictor.29–31 Thus, a potentially more reliable index for PH in patients with pulmonary fibrosis and other causes of ILD is the ratio of the dMPA to the dAa examined on the same transverse slice of the level of the pulmonary artery bifurcation and the widest short-axis dAa, and the mean ratio was found to be 1.1.30 A later study found that the diameter of the PA and the cross-sectional area of the PA as a ratio to the ascending aorta correlated equally well to the invasive PA measurement.32 Our dogs had a mean ratio of 1.1 (range: 0.86–1.63), and the value of this ratio still needs to be determined in dogs. Pulmonary artery diameters (average of the left and right pulmonary arteries) have also found to be predictive of death in patients with PH and bronchiectasis.33 CT reconstructions using multiplanar reformatting of the RV and left ventricular volumes can be calculated and compared. The RV to left ventricular volume ratios have been shown to correlate well with pulmonary artery pressures measured by cardiac catheterization (R=0.82, P<0.001).34 In our study, multiplanar reformatting was not possible, but in three dogs, the average ratio of RV to left ventricular internal diameter was 106%; considering the right ventricle should be <50% of the left ventricular internal diameter, this value was considered significant. Thus, a number of noninvasive CT measurements can be used to predict PH in people. The application of thoracic CT for noninvasively assessing the pulmonary arteries in dogs has already standardized the pulmonary artery size, using the bronchial lumen (internal diameter) at the same CT section as a reference, measured at the level of the fourth and eleventh ribs for the cranial and caudal lobar arteries, respectively, with BA ratios in normal dogs having a mean of 1.45±0.21 (99% confidence interval [CI] 1.34–1.56).12 The mean BA in our study, using the identical measurements (n=6), was 0.72 (range: 0.5–0.93), indicative of significant larger pulmonary arteries in our group of dogs as compared to the study by Cannon et al and should be considered as a potential CT index in predicting PH (2009). In the five dogs that had bronchoscopy and BAL performed, there was no endoscopic evidence of traction bronchiectasis, and the cytology was consistent with a pan class="Disease">neutrophilic inflammation in only two dogs (50%–80% neutrophils). Bronchoscopy changes in IPF have been described as irregular mucosa, bronchial mucous, mild bronchiectasis, bronchomalacia; bacteria are not demonstrated on bronchoalveolar cytology or cultured, and in the four of the five dogs that had cellular BAL samples, neutrophils (50%–80%) predominated with macrophages (84%) in the other; although this is considered a normal cell type, the remainder (15/20) did not have any significant inflammation.13 In contrast, BAL cytology in EBP is consistent with an abnormal eosinophilia.14

Limitations

The main limitation of this study is the lack of lung histopathology and is due to the cultural opposition to necropsy in the region. Lung biopsy is associated with a high complication rate and mortality; two of eleven dogs and one of three pan class="Species">dogs with ILD in two case series died as a complication.16,35 Lung biopsy was not offered to any of the clients due to the severe respiratory compromise of the dogs at the time of diagnosis. Anecdotally, a number of etiologies and pathogenesis including pollution and chronic high-pressure dynamics induced from chronic brachycephalic obstructive airway syndrome are possibilities. It cannot be established what the true prevalence of PH and chronic idiopathic ILD is in Pekingese without syncope and dyspnea as these dogs are unlikely to present to a veterinarian as chronic exercise intolerance could be assumed to be due to old age or brachycephalic obstructive airway syndrome. Ideally, a prospective study recruiting middle-aged Pekingese and performing sequential thoracic radiographs and echocardiography should be implemented. Postmortem with histopathology of the lungs should be able to elucidate the etiology of this syndrome but may prove difficult in this region.
  30 in total

1.  Bronchiolitis obliterans with organizing pneumonia in a dog.

Authors:  S Phillips; S Barr; N Dykes; P Scrivani; M Kraus; M Rishniw; B Valentine
Journal:  J Vet Intern Med       Date:  2000 Mar-Apr       Impact factor: 3.333

Review 2.  Pulmonary veno-occlusive disease.

Authors:  J Mandel; E J Mark; C A Hales
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

3.  Thoracic high-resolution computed tomographic findings in dogs with canine idiopathic pulmonary fibrosis.

Authors:  V S Johnson; B M Corcoran; P R Wotton; T Schwarz; M Sullivan
Journal:  J Small Anim Pract       Date:  2005-08       Impact factor: 1.522

4.  Guidelines for the diagnosis and treatment of canine chronic valvular heart disease.

Authors:  C Atkins; J Bonagura; S Ettinger; P Fox; S Gordon; J Haggstrom; R Hamlin; B Keene; V Luis-Fuentes; R Stepien
Journal:  J Vet Intern Med       Date:  2009-09-22       Impact factor: 3.333

5.  Computed tomography bronchial lumen to pulmonary artery diameter ratio in dogs without clinical pulmonary disease.

Authors:  Matthew S Cannon; Erik R Wisner; Lynelle R Johnson; Philip H Kass
Journal:  Vet Radiol Ultrasound       Date:  2009 Nov-Dec       Impact factor: 1.363

6.  Measurements of the pulmonary vasculature on thoracic radiographs in healthy dogs compared to dogs with mitral regurgitation.

Authors:  Heejin Oui; Juyeon Oh; Seoyeon Keh; Gahyun Lee; Sunghoon Jeon; Hyunwook Kim; Junghee Yoon; Jihye Choi
Journal:  Vet Radiol Ultrasound       Date:  2014-12-28       Impact factor: 1.363

7.  Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005-2014.

Authors:  Heidi B Kellihan; Kenneth R Waller; Alyssa Pinkos; Howard Steinberg; Melissa L Bates
Journal:  J Vet Cardiol       Date:  2015-08-17       Impact factor: 1.701

8.  Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992-1996.

Authors:  L Johnson; J Boon; E C Orton
Journal:  J Vet Intern Med       Date:  1999 Sep-Oct       Impact factor: 3.333

Review 9.  Pulmonary hypertension in dogs: diagnosis and therapy.

Authors:  Heidi B Kellihan; Rebecca L Stepien
Journal:  Vet Clin North Am Small Anim Pract       Date:  2010-07       Impact factor: 2.093

10.  Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis.

Authors:  Elodie Roels; Emilie Krafft; Frederic Farnir; Saila Holopainen; Henna P Laurila; Minna M Rajamäki; Michael J Day; Nadine Antoine; Dimitri Pirottin; Cecile Clercx
Journal:  Vet J       Date:  2015-06-04       Impact factor: 2.688

View more
  3 in total

1.  Comparison between Image-Guided Transbronchial Cryobiopsies and Thoracoscopic Lung Biopsies in Canine Cadaver: A Pilot Study.

Authors:  Ilaria Falerno; Roberto Tamburro; Francesco Collivignarelli; Leonardo Della Salda; Luigi Navas; Rossella Terragni; Paolo Emidio Crisi; Andrea Paolini; Francesco Simeoni; Massimo Vignoli
Journal:  Animals (Basel)       Date:  2022-05-28       Impact factor: 3.231

2.  Tricuspid valve chordal rupture in a dog with pulmonary hypertension.

Authors:  Tomoki Maeba
Journal:  Open Vet J       Date:  2021-10-01

3.  ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.

Authors:  Carol Reinero; Lance C Visser; Heidi B Kellihan; Isabelle Masseau; Elizabeth Rozanski; Cécile Clercx; Kurt Williams; Jonathan Abbott; Michele Borgarelli; Brian A Scansen
Journal:  J Vet Intern Med       Date:  2020-02-17       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.